AS160 modulates aldosterone-stimulated epithelial sodium channel forward trafficking.
Aldosterone-induced increases in apical membrane epithelial sodium channel (ENaC) density and Na transport involve the induction of 14-3-3 protein expression and their association with Nedd4-2, a substrate of serum- and glucocorticoid-induced kinase (SGK1)-mediated phosphorylation. A search for other 14-3-3 binding proteins in aldosterone-treated cortical collecting duct (CCD) cells identified the Rab-GAP, AS160, an Akt/PKB substrate whose phosphorylation contributes to the recruitment of GLUT4 transporters to adipocyte plasma membranes in response to insulin. In CCD epithelia, aldosterone (10 nM, 24 h) increased AS160 protein expression threefold, with a time-course similar to increases in SGK1 expression. In the absence of aldosterone, AS160 overexpression increased total ENaC expression 2.5-fold but did not increase apical membrane ENaC or amiloride-sensitive Na current (I(sc)). In AS160 overexpressing epithelia, however, aldosterone increased apical ENaC and I(sc) 2.5-fold relative to aldosterone alone, thus recruiting the accumulated ENaC to the apical membrane. Conversely, AS160 knockdown increased apical membrane ENaC and I(sc) under basal conditions to approximately 80% of aldosterone-stimulated values, attenuating further steroid effects. Aldosterone induced AS160 phosphorylation at five sites, predominantly at the SGK1 sites T568 and S751, and evoked AS160 binding to the steroid-induced 14-3-3 isoforms, beta and epsilon. AS160 mutations at SGK1 phospho-sites blocked its selective interaction with 14-3-3beta and epsilon and suppressed the ability of expressed AS160 to augment aldosterone action. These findings indicate that the Rab protein regulator, AS160, stabilizes ENaC in a regulated intracellular compartment under basal conditions, and that aldosterone/SGK1-dependent AS160 phosphorylation permits ENaC forward trafficking to the apical membrane to augment Na absorption.
Liang
Xiubin
X
Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Butterworth
Michael B
MB
Peters
Kathryn W
KW
Frizzell
Raymond A
RA
D048948:14-3-3 Proteins / Q000378:metabolism; D000450:Aldosterone / Q000494:pharmacology*; D000818:Animals; D016764:Cell Polarity / Q000187:drug effects; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D053503:Epithelial Sodium Channels / Q000378:metabolism*; D020690:GTPase-Activating Proteins / Q000378:metabolism*; D055785:Gene Knockdown Techniques; D015640:Ion Channel Gating / Q000187:drug effects*; D007685:Kidney Tubules, Collecting / Q000166:cytology; D051379:Mice; D008954:Models, Biological; D009154:Mutation / Q000235:genetics; D010766:Phosphorylation / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D021381:Protein Transport / Q000187:drug effects; D012964:Sodium / Q000378:metabolism
D048948:14-3-3 Proteins; D053503:Epithelial Sodium Channels; D020690:GTPase-Activating Proteins; C505647:Tbc1d4 protein, mouse; D000450:Aldosterone; D012964:Sodium
J Biol Chem. 2006 Jun 16;281(24):16323-32
16613846
J Am Soc Nephrol. 2005 Nov;16(11):3154-9
16192416
J Am Soc Nephrol. 2007 Apr;18(4):1084-92
17344426
Semin Cancer Biol. 2006 Jun;16(3):173-82
16678437
Am J Physiol Renal Physiol. 2001 Jan;280(1):F112-8
11133521
J Clin Invest. 1999 Oct;104(7):R19-23
10510339
Physiol Rev. 1999 Jan;79(1 Suppl):S215-55
9922383
Trends Biochem Sci. 2006 Apr;31(4):215-22
16540333
Am J Physiol Renal Physiol. 2001 Feb;280(2):F303-13
11208606
Am J Physiol Renal Physiol. 2001 Apr;280(4):F675-82
11249859
Am J Physiol Renal Physiol. 2006 Jun;290(6):F1285-94
16682484
Am J Physiol Renal Physiol. 2000 Aug;279(2):F252-8
10919843
PLoS Biol. 2006 Dec;5(1):e5
17177604
J Biol Chem. 2007 Dec 28;282(52):37885-93
17967898
J Biol Chem. 2003 Apr 25;278(17):14599-602
12637568
J Biol Chem. 2007 Oct 12;282(41):29866-73
17715136
Curr Opin Nephrol Hypertens. 2005 Jan;14(1):59-66
15586017
J Biol Chem. 2006 May 19;281(20):14129-35
16574660
Am J Physiol Renal Physiol. 2009 Jan;296(1):F10-24
18508877
Annu Rev Pharmacol Toxicol. 2000;40:617-47
10836149
Mol Biol Cell. 2003 Jul;14(7):2677-88
12857856
Mol Cell Proteomics. 2009 Nov;8(11):2487-99
19648646
Mol Endocrinol. 2005 Dec;19(12):3073-84
16099816
J Biol Chem. 2006 Sep 29;281(39):29174-80
16880201
Am J Physiol Renal Physiol. 2002 Apr;282(4):F559-76
11880316
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2712-6
11226305
Mol Cell. 1998 Sep;2(3):397-403
9774978
Biochem J. 2007 Oct 15;407(2):231-41
17617058
J Gen Physiol. 2002 Jul;120(1):71-85
12084777
J Biol Chem. 2008 Oct 10;283(41):27418-27425
18687683
Am J Respir Crit Care Med. 2008 Apr 1;177(7):730-42
18079494
Am J Physiol Renal Physiol. 2002 Aug;283(2):F221-35
12110505
Am J Physiol Renal Physiol. 2006 Oct;291(4):F714-21
16720863
Biochem J. 2004 Apr 15;379(Pt 2):395-408
14744259
Endocr Rev. 2002 Apr;23(2):258-75
11943747
Biochem J. 2005 Oct 1;391(Pt 1):87-93
15971998
J Gen Physiol. 2005 Jan;125(1):81-101
15623897
Am J Physiol Renal Physiol. 2006 Sep;291(3):F683-93
16554417
Cell Metab. 2008 Nov;8(5):344-6
19046566
Mol Cell Biol. 2006 Dec;26(24):9497-507
17030608